Free Trial

Sunshine Biopharma (SBFMW) Competitors

Sunshine Biopharma logo
$0.19 -0.04 (-17.39%)
As of 05/23/2025 03:59 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

SBFMW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, and CELUW

Should you be buying Sunshine Biopharma stock or one of its competitors? The main competitors of Sunshine Biopharma include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry.

Sunshine Biopharma vs.

180 Life Sciences (NASDAQ:ATNFW) and Sunshine Biopharma (NASDAQ:SBFMW) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their community ranking, profitability, institutional ownership, analyst recommendations, risk, valuation, earnings, dividends and media sentiment.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
Sunshine Biopharma$36.23MN/AN/AN/AN/A

In the previous week, Sunshine Biopharma had 1 more articles in the media than 180 Life Sciences. MarketBeat recorded 1 mentions for Sunshine Biopharma and 0 mentions for 180 Life Sciences. 180 Life Sciences' average media sentiment score of 0.00 equaled Sunshine Biopharma'saverage media sentiment score.

Company Overall Sentiment
180 Life Sciences Neutral
Sunshine Biopharma Neutral

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
Sunshine Biopharma N/A N/A N/A

180 Life Sciences and Sunshine Biopharma both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
180 Life SciencesN/AN/A
Sunshine BiopharmaN/AN/A

Summary

Sunshine Biopharma beats 180 Life Sciences on 2 of the 2 factors compared between the two stocks.

Get Sunshine Biopharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for SBFMW and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SBFMW vs. The Competition

MetricSunshine BiopharmaDrug Manufacturers IndustryMedical SectorNASDAQ Exchange
Market CapN/A$2.17B$5.33B$8.31B
Dividend YieldN/A2.92%5.27%4.10%
P/E RatioN/A4.0126.7119.58
Price / SalesN/A569.73395.62135.28
Price / CashN/A10.2538.3234.62
Price / BookN/A7.036.764.50
Net IncomeN/A$20.70B$3.23B$248.40M
7 Day Performance25.88%-0.17%0.36%-0.85%
1 Month Performance-2.73%2.28%7.03%8.09%
1 Year PerformanceN/A96.34%18.59%8.75%

Sunshine Biopharma Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SBFMW
Sunshine Biopharma
N/A$0.21
-7.0%
N/A+52.9%$0.00$36.23M0.003News Coverage
Gap Up
ATNFW
180 Life Sciences
N/A$0.01
-3.2%
N/A+13.6%$0.00N/A0.007
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522,000.000.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.02
+282.4%
N/AN/A$0.00N/A0.002Gap Up
AIMDW
Ainos
N/A$0.10
-24.2%
N/AN/A$0.00$20,729.000.0040Gap Up
ALVOW
Alvotech
N/A$1.77
-1.1%
N/A-38.8%$0.00$489.68M0.004
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.02
+2.5%
N/A-83.1%$0.00N/A0.0015
BFRIW
Biofrontera
N/A$0.10
-25.5%
N/A+72.0%$0.00$37.32M0.0070Gap Down
BTMDW
biote
N/A$0.02
+43.9%
N/A-94.8%$0.00$199.38M0.00N/AHigh Trading Volume
BCTXW
BriaCell Therapeutics
N/A$0.05
-17.1%
N/A-81.0%$0.00N/A0.008
CELUW
Celularity
N/A$0.04
-6.3%
N/AN/A$0.00$54.22M0.00220Positive News

Related Companies and Tools


This page (NASDAQ:SBFMW) was last updated on 5/24/2025 by MarketBeat.com Staff
From Our Partners